Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery
​​​​​​​A major clinical trial, led by the University of ΞΆΓάΘ¦, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before and after surgery.